The Future of the CRA: Perspectives from Clinical Operations Leaders Across the Industry

Featuring leaders from AstraZeneca, Boehringer Ingelheim Pharmaceuticals Inc., IPSEN, and a biopharmaceutical executive with experience across Merck, Sanofi, and Johnson & Johnson

INSPIRE. CONNECT. INNOVATE.

On-Demand Webinar

The CRA Talent and Skill Evolution: From Oversight to Enablement, From Fact Checker to Strategic Partner

As clinical trials become more complex, decentralized and data-driven, the Clinical Research Associate is evolving from monitor and fact checker to strategic site partner, risk navigator and delivery enabler.
Today, CRA success is no longer measured solely by visit volume or pages verified alone. Their impact is increasingly defined by how effectively they strengthen site relationships, anticipate operational challenges, support recruitment and retention, interpret risk signals and improve trial quality.
This whitepaper explores what this evolution means for clinical operations leaders, sponsors and talent strategists.

In this paper you’ll learn:

  • How leading sponsors are redefining CRA success
  • What workforce trends mean for future trial delivery
  • Why skills-based hiring may unlock hidden talent pools
  • How organizations can avoid future workforce pipeline challenges
  • What capabilities tomorrow’s CRA will need to succeed

Whitepaper Participants

Karen Correa, PhD

VP, US CDO
Boehringer Ingelheim Pharmaceuticals, Inc.

Nick Hodges

Senior Vice President Head of Clinical Development Operations
IPSEN

David Carruthers

Vice President Clinical Operations
AstraZeneca

Mark Travers, PhD, MBA

Biopharmaceutical Leader
Former Merck, Sanofi & JnJ Executive

Diana Cucos, PhD

Global Head, FSP 360 & Modular Solutions
Syneos Health

Checkboxes (copy)

© 2026 Marketing Masters Hub. All rights reserved.

 
Scroll to Top